Nine patients with carcinoma of the esophagus treated by prosthetic tubes are reviewed. The ease of this surgery, simplicity of care and the improvement in the quality of life postoperatively is contrasted to that of patients who have otber treatment. The indications for prosthetic tubes are presented.
arcinorna of the esophagus comprises 2 percent of all malignant tumors and 10 percent of all esophagogastrointestinal tumors. The national figures in Table 1 ' point out the magnitude of the problem. The treatment of this condition is palliative in some 75 percent of the cases, since at diagnosis 75 percent of the cases have regional or distant nodal metastases. In untreated patients, 75 percent die within one year of the onset of syrnp toms.
The first successful resection of the esophagus was camed out by Czerny in 1877. 2 Adams and Phemi~ter,~ in 1938, showed the feasibility of esophagogastrectomy. Recent series and collective reviews of the management of cancer of the esophagus continue to point up the difficulty in successful treatment and the poor longterm result^."^ Few of these emphasize the place of prosthetic tubes in this d' isease.
The first successful use of an indwelling esophageal tube to maintain a lumen through & n o r w a s described by Symonds in 1885.8 This was followed by Souttar's flexible spiral silver wire tube in 1927.9 Subsequently, tubes were described by Mackler In this series the Celestin tube was used because of its flexibility, design and mode of insertion. Because it is positioned by traction on the guiding bougie in the stomach, perforation is less likely and simultaneous endoscopy enables the detection and immediate correction of the tube's collapse, coverage or obstruction. Also, the use of a transfixation suture lessens migration.
In a five-year period from 1966 to 1971, 40 patients with carcinoma of the esophagus were seen at St. Elizabeth's Hospital, and nine of these were treated by placement of prosthetic tubes, eight Celestin and one Mackler tube (Table 2 ). Only two of these patients had a thoracotomy before placement of the tube. At laparotomy, all of the patients had significant periaortic nodal involvement. The average survival post placement of the tube has been 4.8 months. The complications of our series are listed in Table 3 . The cause of death was related to the underlying disease in the majority of patients. However, two patients had delayed esophageal perforation, and patient number 6, who had a T-E fistula preoperatively, was not helped by the tube, but succumbed on the fifth postoperative day of sepsis. Therefore, three of nine patients died in the hospital and a 67 percent palliation was achieved. There was no operative mortality. Duvoisin et alls achieved 73 percent palliation in 59 patients, with 9 percent operative mortality.
PROSTHETIC TUBES IN CARCINOMA OF THE ESOPHAGUS
Other complications have been catalogued by AdamsI4: fever, prolapse, reflux esophagitis, wound infection, migration of the tube, loss of patency ( food impaction, tumor obstruction ), tube pressure causing bleeding, edema, emsion, fistula formation and impingement on adjacent organs.
The comparable operative mortality of palliative resection including bypass procedure for this lesion varies from 10 percent to 40 p e r~e n t .~~~~' " '~ Gastrostomy does not solve the problem of secretions, and is associated with a mortality of 16 percent or higher.1Q.20 It also does not increase the quality of life. Radiotherapy results are not predictable, carry a 10 percent mortality, and often do not solve the swallowing problem.21 Bougienage has been suggested as a palliative measure, but because of the danger of perforation, its supporters are f e~.~~,~~ Our indications for the insertion of a Celestin tube are given in Table 4 . Our average postoperative hospital stay was ten days, and all of the patients were able to go home directly. At two weeks follow-up, no patient was restricted to his home, and all were tolerating feedings well. Their families were surprised at the relative comfort of the patient, and the facility of caring for him. This course is in contradistinction to -patients who have resection, with or without radiotherapy. A large number of the latter group require prolonged hospitalization, extensive care and undergo major morbidity and stress. Furthermore, many of these patients still have to be transferred to extended care facilities for long periods.
There is, then, a definite place in the treatment of carcinoma of the esophagus for the use of the Celestin tube, because of the stage of the disease when the diagnosis is made. The use of prosthetic tubes will not prolong the life of the patient, but the restoration of the swallowing mechanism is of great value and thereby it enhances the patient's life. The argument presented by Wilkins and Skinner that treatment should be more aggressive, because resec- tion and radiotherapy alone markedly prolong longevity is not entirely without fault, since the quality of life prolonged may be somewhat less than d e~i r a b l e .~~.~~ The use of the Celestin tube circumvents, in many cases, the need for an unnecessary thoracotomy, major morbidity and stress in an already advanced and depressing situation. This tube enables one to make the patient relatively comfortable by restoring his swallowing function via a comparatively minor procedure. Its use should be considered not as a substitute for aggressive eradication of operable diseases, but in those situations discussed above.
